# Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years

> **NCT00464217** · PHASE4 · COMPLETED · sponsor: **PETHEMA Foundation** · enrollment: 100 (—)

## Conditions studied

- Acute Myeloblastic Leukaemia

## Interventions

- **DRUG:** ARA-C
- **DRUG:** Idarubicin
- **DRUG:** Leucomax

## Key facts

- **NCT ID:** NCT00464217
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 100 (—)
- **Last updated:** 2010-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00464217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00464217, "Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 Years". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00464217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*